NCT04996017 2025-03-13AtezoMesoGruppo Oncologico Italiano di Ricerca ClinicaPhase 3 Recruiting162 enrolled
NCT06090318 2023-10-19Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossRain Oncology IncPhase 1/2 Withdrawn